GAE vs. Cortisone, Gel Injections, PRP, and Nerve Ablation: How the Non-Surgical Knee Options Actually Compare

Most patients we see have already been through several rounds of something. Cortisone. Maybe gel injections. Maybe physical therapy for six months. Possibly a conversation about PRP or stem cells at a clinic that advertised on the radio.

And the pattern is usually the same. The first injection worked well. The second worked a little less well. The third barely moved the needle. Now the orthopedist is bringing up knee replacement and it feels like a bigger step than you are ready for.

If that is where you are, this is a comparison worth having in one place. Here is how the non-surgical options for knee osteoarthritis actually differ, what the evidence supports, and where genicular artery embolization fits among them.

First, a framing that makes the whole thing clearer

These treatments are not competing versions of the same thing. They work on completely different targets:

• Cortisone suppresses inflammation chemically, briefly.
• Gel injections (hyaluronic acid) aim to improve the joint's lubricating fluid.
• PRP and cell-based therapies attempt to influence the joint's biology and healing environment.
• Genicular nerve ablation interrupts the pain signal traveling from the knee to the brain.
• GAE reduces the abnormal blood vessels that are feeding the inflammation in the first place.

Once you see them that way, the question stops being "which one is best" and becomes "which mechanism matches what is actually driving my pain."

Corticosteroid (cortisone) injections

What it does: Delivers a potent anti-inflammatory directly into the joint.

How long it lasts: Typically weeks to a few months. Most patients notice the effect fading, and many notice each subsequent injection lasting less time than the one before it.

Where the guidelines land: Corticosteroid injections are among the more consistently recommended intra-articular options across major clinical guidelines, and they are widely covered by insurance.

The limitations: Frequency is limited, generally to a few injections per joint per year. There is ongoing discussion in the orthopedic literature about the effects of repeated corticosteroid exposure on cartilage over time. And critically, cortisone treats the inflammation that exists today. It does nothing about the mechanism generating it.

When it makes sense: Flares, bridging to another treatment, and patients who get durable relief from them. If cortisone is still giving you four months of real comfort, keep doing it.

Hyaluronic acid, also called gel injections or viscosupplementation

What it does: Injects a lubricating, shock-absorbing substance intended to supplement the joint fluid.

How long it lasts: Variable. Some patients report several months. Others report nothing.

Where the guidelines land: This is the most contested option on the list. The American Academy of Orthopaedic Surgeons does not recommend hyaluronic acid injections for routine use in symptomatic knee osteoarthritis. The American College of Rheumatology conditionally recommends against them for the knee. Other bodies, including OARSI, have been more permissive. Large network meta-analyses have struggled to demonstrate clinically meaningful benefit over placebo at three to six months.

The honest read: Gel injections remain widely used and many patients believe they help. But the evidence base is genuinely mixed, and the major guideline bodies do not agree with each other. If you have had a gel series and felt nothing, that is a common experience and not a personal failure.

When it makes sense: Patients who have had a clear, repeatable response to it.

PRP and cell-based therapies

What it does: PRP concentrates platelets from your own blood and injects them into the joint, aiming to influence the inflammatory and healing environment. Cell-based therapies use various preparations marketed as regenerative.

Where the guidelines land: This is where you need to be a careful consumer. AAOS offers only limited support for PRP and does not recommend it for routine use. The American College of Rheumatology strongly recommends against both PRP and cell-based therapies for knee osteoarthritis, and OARSI does the same. Some recent reviews suggest leukocyte-poor PRP may outperform hyaluronic acid and corticosteroid in mild-to-moderate disease, but preparation protocols vary so widely between clinics that results are difficult to compare.

The practical problem: These are almost never covered by insurance. Medicare does not cover stem cell treatments for knee osteoarthritis. That means significant out-of-pocket cost for a treatment with a contested evidence base and no standardization between providers.

When it makes sense: Some younger patients with mild disease, with clear eyes about cost and evidence. Be wary of any clinic promising cartilage regrowth.

Genicular nerve ablation, sometimes called genicular nerve RFA

What it does: Uses radiofrequency energy to interrupt the small sensory nerves carrying pain signals from the knee. Often preceded by a diagnostic nerve block to confirm you will respond.

How long it lasts: Commonly six to twelve months. Nerves regenerate over time, so the effect is not permanent and the procedure is often repeated.

The trade-off: Nerve ablation is a legitimate, evidence-supported option, and for the right patient it works well. But conceptually it is a volume knob on the pain signal. It does not change what is happening inside the joint. The inflammation continues; you just feel less of it.

How it compares to GAE: This is a real clinical question and it is being studied directly. Randomized trials comparing GAE against genicular nerve ablation are underway, and published cost-effectiveness analyses have compared embolization, radiofrequency ablation, and corticosteroid therapy head to head. The two approaches are not mutually exclusive, and there is published work on combining them in difficult cases, particularly for persistent pain after knee replacement.

Worth noting: because the names are so similar, patients frequently confuse genicular artery embolization with genicular nerve ablation. They are different procedures with different targets and usually different specialists.

When it makes sense: Patients whose pain is well localized to the nerve distributions, patients who respond strongly to a diagnostic block, and patients for whom vascular access is a problem.

Genicular artery embolization

What it does: In an osteoarthritic knee, the body grows abnormal new blood vessels into the joint lining. Those vessels bring nerve fibers with them and sustain a cycle of inflammation and pain sensitization. GAE uses a catheter, guided by live imaging through a puncture no bigger than a pen tip, to deliver microscopic particles that selectively reduce blood flow to those abnormal vessels.

How long it lasts: Published data shows meaningful pain and function improvement sustained at twelve months and beyond in appropriately selected patients, with pooled improvements on standard pain and function scales exceeding the threshold for clinical significance. Cumulative success rates around 85% at two years have been reported for mild to moderate osteoarthritis.

The trade-offs, stated plainly: It is more involved than an injection. It is a catheter-based procedure requiring a specialist and an imaging suite. It has its own side effect profile, most commonly temporary skin discoloration. Insurance coverage is less consistent than it is for cortisone. And it is not a cure. It does not regrow cartilage or reverse the structural changes in the joint.

When it makes sense: Patients with mild to moderate osteoarthritis whose injections are producing shorter and shorter windows of relief, patients who want to delay or avoid knee replacement, patients who face elevated surgical risk, and patients with persistent pain after a knee replacement.
‍

The signal that it is time to look at something different

The clearest sign is the pattern most patients recognize immediately: your injections are working for less and less time.

The first cortisone shot gave you six months. The next gave you three. The last one gave you six weeks. That trajectory usually means the inflammatory process driving your pain has become self-sustaining, and treatments that suppress inflammation temporarily are being outpaced by the mechanism generating it.

That is precisely the situation GAE was developed to address.

Frequently Asked Questions

What should I do when cortisone shots stop working?

Diminishing returns from cortisone is one of the most common reasons patients come to the Vascular Center of Naples. It usually signals that the underlying inflammatory process needs a different kind of intervention rather than another round of the same one. That is worth a conversation, not a longer wait.

‍

Is GAE better than genicular nerve ablation?

They target different things, so "better" depends on your situation. Ablation quiets the pain signal; GAE reduces the abnormal blood supply sustaining the inflammation. Randomized head-to-head trials are underway. In practice, the right choice depends on your imaging, your symptom pattern, your vascular anatomy, and whether you have responded to a diagnostic nerve block.

‍

Do gel injections actually work?

The evidence is genuinely mixed and the major guideline bodies disagree with each other. AAOS does not recommend them for routine use. Some patients report meaningful relief. If you have had a series and felt nothing, that is a common outcome.

‍

Can I have GAE if I've already tried PRP or stem cell injections?

Yes. Prior intra-articular injections do not disqualify you. Bring the records so Dr. Becker knows what has been tried and how you responded.

‍

Do I have to try everything else before GAE?

Not necessarily. Most good candidates have been through some conservative care, and a documented history of it does strengthen an insurance case. But candidacy is based on your full clinical picture, not a checklist.

‍

Can I combine GAE with other treatments?

Yes. GAE does not preclude physical therapy, medication management, injections, nerve ablation, or knee replacement in the future. It is additive, not exclusive.

‍

If your injections are wearing off faster than they used to, that is worth investigating rather than waiting out. Find out if you're a candidate today and schedule a consultation with Dr. Becker at the Vascular Center of Naples for an honest assessment of which option fits your knee. Call (239) 431-5884.

‍

Find Out If You Are a Candidate

‍

Medical disclaimer: This content is for educational purposes only and does not constitute medical advice. Treatment guidelines and evidence evolve; the comparisons above reflect published clinical guidance as of publication. Please consult a qualified physician for diagnosis and individualized treatment recommendations.

‍